According to Tongbi Finance, on May 29, 2026, Anhui Huangshan Capsule Co., Ltd. (stock abbreviation: Huangshan Capsule, code: 002817.SZ) received a Wind ESG rating of BBB, unchanged from the previous period. The company's comprehensive score is 6.65, higher than the pharmaceutical industry average of 5.85. It ranks 70th among 280 companies in the pharmaceutical industry, placing it in the top 25% of the industry. The scores for the environmental, social, and governance dimensions are 5.25, 4.75, and 6.03, respectively.

Compared to the previous rating, the comprehensive score decreased from 6.69 to 6.65, a drop of 0.04 points. The contribution from management practices decreased from 3.70 to 3.65, a decline of 0.05 points. The contribution from controversy events remained stable at 3.00. In terms of dimensions, the environmental dimension decreased by 0.19 points, the social dimension decreased by 0.90 points, and the governance dimension increased by 1.53 points.

Rating Observation

In the environmental dimension, the company has demonstrated a relatively complete management system and practical capabilities in waste, wastewater, and air management. The company has passed the external re-certification audit for the ISO 14001 environmental management system, covering waste, wastewater, and air management, further consolidating the management foundation for green manufacturing. In terms of waste management, the total amount of waste recycled and reused is 171.09 tons, accounting for 77.08% of the total waste, and through a clear management responsibility system and compliant disposal processes, the effectiveness of waste management is ensured. For wastewater management, the company's wastewater discharge volume is 100,522 tons, with a wastewater discharge per million revenue of 218.32 tons, and all wastewater discharge indicators meet national standards. Additionally, the company achieves full-process traceability of pollutant emissions through regular monitoring, operation of specialized treatment facilities, and implementation of rainwater and sewage diversion measures. However, the disclosure of information related to air emissions and raw material management is relatively brief, and the long-term direction of goals and plans has not yet been clarified.

In the social dimension, the company has demonstrated strong organizational capabilities and practical depth in research and development, innovation, and employee development and training. The company has been certified as a high-tech enterprise and recognized as a national-level specialized and innovative small giant, with R&D investment reaching 12.6465 million yuan, accounting for 2.75% of operating revenue, and the proportion of R&D employees is 11.2%, holding a total of 25 valid patents, reflecting its core competitiveness driven by technological innovation. In terms of employee training, the company has established a three-tier training system covering basic theory, practical skills, and advanced management training, with a training coverage rate of 100%. Furthermore, the company promotes employee capability enhancement and knowledge sharing through external training courses and internal knowledge communities. However, the disclosure of information regarding product recall rates and drug vigilance still needs improvement.

In the governance dimension, the company has demonstrated a relatively mature structure and practices in board independence and ESG governance mechanisms. The proportion of independent directors on the board is 33.33%, and there are no independent directors whose terms exceed 6 years or who serve as independent directors in more than 3 listed companies, and the CEO does not concurrently serve as the chairman, indicating a certain degree of governance independence. The company has established a board strategy and sustainable development committee and built a three-tier ESG governance structure, fully incorporating sustainable development performance indicators into the executive compensation assessment system Regular ESG specialized training is also conducted to enhance the practical capabilities of the management team. The proportion of female board members is 22.22%, indicating room for improvement in gender diversity. In addition, the relevant information disclosure regarding the anti-corruption management system and the risk management committee has not yet been covered.

Content generated by AI on May 29, 2026, please verify important information